Pieris Publication

Simultaneous costimulatory T-cell engagement and checkpoint inhibition by PRS- 344/S095012, a 4-1BB/PD-L1 bispecific compound for tumor-localized activation of the immune system. AACR 2021.

By June 23, 2025June 24th, 2025No Comments

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Skip to content